Jeff Goater - Jun 10, 2021 Form 4 Insider Report for Surface Oncology, Inc. (SURF)

Role
Director
Signature
/s/ Jessica Fees, as Attorney-in-Fact
Stock symbol
SURF
Transactions as of
Jun 10, 2021
Transactions value $
-$900,545
Form type
4
Date filed
6/11/2021, 08:30 PM
Previous filing
May 12, 2021
Next filing
Jun 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SURF Common Stock Options Exercise $828K +200K +76.34% $4.14 462K Jun 10, 2021 Direct
transaction SURF Common Stock Options Exercise $144K +34.7K +7.52% $4.14 497K Jun 10, 2021 Direct
transaction SURF Common Stock Sale -$1.8M -235K -47.25% $7.66* 262K Jun 10, 2021 Direct F1
transaction SURF Common Stock Options Exercise $42.5K +10.3K +3.92% $4.14 272K Jun 11, 2021 Direct
transaction SURF Common Stock Sale -$116K -15.3K -5.61% $7.61* 257K Jun 11, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SURF Stock Option (Right to Buy) Options Exercise $0 -200K -65.77% $0.00 104K Jun 10, 2021 Common Stock 200K $4.14 Direct F3
transaction SURF Stock Option (Right to Buy) Options Exercise $0 -34.7K -77.08% $0.00 10.3K Jun 10, 2021 Common Stock 34.7K $4.14 Direct F4
transaction SURF Stock Option (Right to Buy) Options Exercise $0 -10.3K -9.87% $0.00 93.8K Jun 11, 2021 Common Stock 10.3K $4.14 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $7.56 to $7.82. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $7.58 to $7.64. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The stock option is fully vested and exercisable as of the date hereof.
F4 The stock option vests and becomes exercisable in 48 equal monthly installments after the closing of the Issuer's initial public offering.